SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GSII - GENERAL SURGICAL INNOVATIONS, INC.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stewart Elliot who wrote (190)4/27/1999 1:29:00 PM
From: Epics   of 211
 
From what I hear, there isn't much Guidant can do to the injunction. They can appeal the 12 million, however considering they have taken a charge and can't do anything regardng the injunction, they will pay up. GSI is attempting to locate the existing client base of Guidant to convince them to go to GSII before the November 15 drop dead date. GSII has maybe 4 million in revenues, about 1 mill per quarter. With this market even if they obtain 10% of a 60 million excluding royalties and cash in the bank, that would be 10 million revs over the next year with easy year over year comparisons. Any royalties or cash would be an added bonus. Don't think this stock will take off till next earnings, because I think the street might recognize the fundamentals plus the earnings momentum. I think the last quarter was the last puke job. Things look better from here, think some people got tired of waiting, hence the recent weakness in the stock. However, with no volume I think everyone who wanted to sell has sold. This can be a 10 dollar stock 6 months out. Any decent execution of Guidant's base. They have 23% revenue growth last quarter and they haven't really tried yet.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext